U.S. TB Incidence Increased in 2022, With Ongoing Racial and Ethnic Disparities

A U.S. surveillance report describes tuberculosis incidence trends for 2022. The report covers the entire United States population, though specific sample sizes and demographic breakdowns are not reported. No specific intervention, exposure, or comparator was analyzed in this descriptive report.

The main finding was an increase in TB incidence in the United States during 2022 compared to prior years. The exact magnitude of the increase, absolute case numbers, and statistical measures are not reported. A second key finding was the persistence of disparities in TB incidence among certain racial and ethnic groups, though the specific groups and the size of the disparities are not detailed.

No safety or tolerability data are reported, as this was not a clinical trial. Key limitations include the descriptive nature of the report, which cannot establish causality or identify specific drivers of the increase or disparities. The lack of reported effect sizes, confidence intervals, and granular demographic data limits detailed interpretation.

For clinical practice, this report serves as a reminder for healthcare providers to maintain awareness of TB, particularly in populations historically bearing a disproportionate burden. The findings underscore that TB remains a public health concern requiring sustained surveillance and equitable public health strategies.